Meprobamate (Alembic Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Meprobamate drug offered from Alembic Pharmaceuticals Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Alembic Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Meprobamate |
| SUBSTANCE NAME: | MEPROBAMATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-03-31 |
| END MARKETING DATE: | 0000-00-00 |
Meprobamate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Meprobamate from Alembic Pharmaceuticals Inc. |
| LABELER NAME: | Alembic Pharmaceuticals Inc. |
| DEA SCHEDULE: | CIV
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2016-03-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 62332-019_2f83665d-f4a7-4503-ab05-e34be087fc3e |
| PRODUCT NDC: | 62332-019 |
| APPLICATION NUMBER: | ANDA090122 |
Other MEPROBAMATE Pharmaceutical Manufacturers / Labelers:
